Abbott Laboratories (ABT)vsEstablishment Labs Holdings Inc (ESTA)
ABT
Abbott Laboratories
$104.83
+0.74%
HEALTHCARE · Cap: $180.82B
ESTA
Establishment Labs Holdings Inc
$59.57
+2.42%
HEALTHCARE · Cap: $1.75B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 20901% more annual revenue ($44.33B vs $211.08M). ABT leads profitability with a 14.7% profit margin vs -24.2%. ABT earns a higher WallStSmart Score of 51/100 (C-).
ABT
Buy51
out of 100
Grade: C-
ESTA
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-315.5%
Fair Value
$25.23
Current Price
$104.83
$79.60 premium
Intrinsic value data unavailable for ESTA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
Revenue surging 45.2% year-over-year
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
Trading at 74.5x book value
ROE of -133.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : ESTA
The strongest argument for ESTA centers on Revenue Growth. Revenue growth of 45.2% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : ESTA
The primary concerns for ESTA are EPS Growth, Market Cap, Price/Book. Debt-to-equity of 15.96 is elevated, increasing financial risk.
Key Dynamics to Monitor
ABT profiles as a value stock while ESTA is a hypergrowth play — different risk/reward profiles.
ESTA carries more volatility with a beta of 0.96 — expect wider price swings.
ESTA is growing revenue faster at 45.2% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (51/100 vs 28/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Establishment Labs Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for cosmetic and reconstructive plastic surgery. The company is headquartered in Alajuela, Costa Rica.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?